Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the financial results ....
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories has informed the stock exchanges that its Board of Directors will meet on Tuesday, November 11, 2025. The agenda includes considering and approving the Standalone and Consolidated Audited Financial Results for the quarter and half year ended September 30, 2025. The company has also confirmed that the trading window for insiders remains closed until November 13, 2025, in line with insider trading regulations. This is a routine regulatory filing with no financial figures disclosed yet.
No immediate impact on shareholders or stock price — this is a standard pre-results intimation. Investors should await the actual Q2/H1 FY26 audited numbers on November 11 for any meaningful insight into the company's performance.